Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

DW-MRI reduces futile surgery in colorectal peritoneal metastases undergoing cytoreductive surgery

Dr Lizzel van der Snee, Dr Max Lahaye and Dr Niels Kok
DW-MRI reduces futile surgery in colorectal peritoneal metastases undergoing cytoreductive surgery ( Dr Lizzel van der Snee, Dr Max Lahaye and Dr Niels Kok )
28 Jan 2026

FFX/bevacizumab plus atezolizumab improves PFS in first-line dMMR/MSI-H mCRC

Dr Caio Rocha Lima - Atrium Health Wake Forest Baptist, Winston-Salem, USA
FFX/bevacizumab plus atezolizumab improves PFS in first-line dMMR/MSI-H mCRC ( Dr Caio Rocha Lima - Atrium Health Wake Forest Baptist, Winston-Salem, USA )
28 Jan 2026

What are the barriers for diverse and inclusive clinical trial recruitment?

Prof Sheeba Irshad - King's College London, London, UK
What are the barriers for diverse and inclusive clinical trial recruitment? ( Prof Sheeba Irshad - King's College London, London, UK )
27 Jan 2026

Immunoprevention and early detection of lung cancer in Africa: The LUNG-GUARD Platform

Dr Chiswili Yves Chabu - University of Missouri, Columbia, USA
Immunoprevention and early detection of lung cancer in Africa: The LUNG-GUARD Platform ( Dr Chiswili Yves Chabu - University of Missouri, Columbia, USA )
27 Jan 2026

Collaboration between North America and Africa to provide equitable cancer care

Dr Dr Abiola Ibraheem - University of Illinois, Illinois, USA
Collaboration between North America and Africa to provide equitable cancer care ( Dr Dr Abiola Ibraheem - University of Illinois, Illinois, USA )
26 Jan 2026

Advancing clinical trials in Africa

Dr Abiola Ibraheem - University of Illinois, Illinois, USA
Advancing clinical trials in Africa ( Dr Abiola Ibraheem - University of Illinois, Illinois, USA )
22 Jan 2026

Tepotinib in second line NSCLC treatment

Dr Antonio Passaro and Prof Raffaele Califano
Tepotinib in second line NSCLC treatment ( Dr Antonio Passaro and Prof Raffaele Califano )
20 Jan 2026

Toripalimab plus chemotherapy improves 3-year survival in resectable gastric/GEJ cancer

Dr Shu-Qiang Yuan - Sun Yat-sen University Cancer Center, Guangzhou, China
Toripalimab plus chemotherapy improves 3-year survival in resectable gastric/GEJ cancer ( Dr Shu-Qiang Yuan - Sun Yat-sen University Cancer Center, Guangzhou, China )
15 Jan 2026

Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma

Dr Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong
Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma ( Dr Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong )
15 Jan 2026

Physical activity reduces fatigue and improves quality of life in colorectal cancer survivors

Dr Louisa Liu - Cedars-Sinai Medical Center, Los Angeles, USA
Physical activity reduces fatigue and improves quality of life in colorectal cancer survivors ( Dr Louisa Liu - Cedars-Sinai Medical Center, Los Angeles, USA )
15 Jan 2026

Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer

Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada
Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer ( Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada )
15 Jan 2026

African Oncogenetics Network: improving training and infrastructure in low-resource regions

Dr Achille Manirakiza - King Faisal Hospital, Kigali, Rwanda
African Oncogenetics Network: improving training and infrastructure in low-resource regions ( Dr Achille Manirakiza - King Faisal Hospital, Kigali, Rwanda )
15 Jan 2026